Triumph & Disaster Gameface Moisturiser
Everything behind the verdicts on this product: the rule that fired for each concern, the three answers and the documents they rest on, every study on the row with the date it was opened, and the versions of the tables that produced them. Nothing here is edited by hand; it is generated from the same records the verdicts are.
The scaleRecommendedGoodSupportingEarly evidenceNot for thisAvoidhow it works
Engine 5.2.0 · rules 0.5.1 · evidence table ev-2026.10-r231 · computed October 13, 2026 · how we decide · the evidence table · the anchors
for Dehydration
Glycerin is a reference standard by mechanism for dehydration; this cream carries it high in the ingredient list.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- Glycerine
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Adequate — concentration not declared; read from the position in the ingredient list
Studied range: 20%, from the trials on the row; needs leave-on contact; judge it after about 1 weeks - 3 · Tolerability
- Standard tolerability
- Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- USP glycerin monograph / Fluhr et al., glycerol and the skin (review) — glycerin is the reference humectant, drawing and holding water in the stratum corneum — reference work
← Back to the verdict All dehydration products → Disclose a concentration or correct a fact →
for Dullness
Glycerin has early or mechanistic evidence for dullness — a reasonable bet, not a recommendation; the other actives here are not yet assessed for it.
The lead active has early or mechanistic evidence only, or is present below a working level. A reasonable bet, not a recommendation.
- Rule
- R9 → Unproven. An active with early or mechanistic evidence only; the product’s category job is not a recognised companion to the concern.
q1 = plausible · supportive = false
Why this rule exists: Plausible-tier actives alone do not earn a recommendation, and 'not for this' would overstate the case against them. 'Unproven' with the evidence dots lets the reader judge the bet (added 0.2.0 after the first shadow run put a 10% niacinamide serum at 'not for this' for hyperpigmentation). 0.5.0: the closing clause reads the other heroes — "nothing else here addresses it" only when every other active has a researched 'none' row; "not yet assessed" when that is the truth. Rows whose dots read moderate or better now reach R9p first.
Rule R9 decided 4,156 verdicts across the catalog; “Unproven” is the verdict on 4,156 of 45,446. The full register. - Carrying active
- Glycerine
- 1 · Standing
- Plausible — trials support it
- 2 · Form
- Adequate — concentration not declared; read from the position in the ingredient list
Studied range: 2–20%, from the trials on the row; needs leave-on contact; judge it after about 1 weeks - 3 · Tolerability
- Standard tolerability
- Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- October 9, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text
← Back to the verdict All dullness products → Disclose a concentration or correct a fact →
for Excess Oiliness
Salicylic Acid has trial-level evidence for excess oiliness but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.
The lead active has at least one trial behind it for the concern but no guideline or regulatory standing yet, and is present at a working level. Short of a recommendation.
- Rule
- R9p → Promising. An active with early or mechanistic evidence only; declared at a working strength, or a labelled active or at a plausible but undeclared level; the product’s category job is not a recognised companion to the concern; moderate or strong evidence dots on the carrier’s row.
q1 = plausible · q2 = adequate | plausible · supportive = false · strength = moderate | strong
Why this rule exists: 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them.
Rule R9p decided 4,872 verdicts across the catalog; “Promising” is the verdict on 4,872 of 45,446. The full register. - Carrying active
- Salicylic Acid
- 1 · Standing
- Plausible — trials support it
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
- 3 · Tolerability
- Standard tolerability — fungal triggers
Cautions: fungal-acne triggers. - Evidence dots
- Moderate evidence
- What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- 30% Supramolecular Salicylic Acid Improved Symptoms and Skin Barrier in Papulopustular Rosacea — Journal of Cosmetic Dermatology — TRUE vehicle (matrix minus SA); investigator-initiated, China Medical University, no declared conflicts (2025), opened July 16, 2026
- Salicylic acid treats acne vulgaris by suppressing AMPK/SREBP1 pathway in sebocytes — Experimental Dermatology — in vitro SEB-1 sebocytes + rabbit ear; NO human data (2019), opened July 16, 2026
- Clinical Efficacy of a Salicylic Acid-Containing Gel on Acne Management and Skin Barrier Function: A 21-Day Prospective Study — Journal of Cosmetic Dermatology — SINGLE-ARM, not an RCT; L'Oréal/CeraVe-employed co-authors testing their own product; EXCLUDED, see notes (2025), opened July 16, 2026
- 30% supramolecular salicylic acid peels effectively treats acne vulgaris and reduces facial sebum — Journal of Cosmetic Dermatology — self-contrast, no control arm; EXCLUDED (2022), opened July 16, 2026
- Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial — Journal of Cosmetic Dermatology — randomized, but BOTH arms received the SA serum (mask vs no mask); no vehicle arm; all authors L'Oréal China; EXCLUDED (2023), opened July 16, 2026
- 2% supramolecular salicylic acid hydrogel vs. adapaline gel in mild to moderate acne vulgaris treatment: A multicenter, randomized, evaluator-blind, parallel-controlled trial. — Journal of Cosmetic Dermatology — n=500, 16 weeks; sebum was MEASURED but the comparator is adapalene, not vehicle, and the abstract reports no sebum result; full text not in PMC. EXCLUDED (no vehicle arm; endpoint result unreported) (2024), opened October 13, 2026
← Back to the verdict All excess oiliness products → Disclose a concentration or correct a fact →
for Rough Texture
Salicylic Acid is a reference standard by mechanism for rough texture; this cream carries it.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- Salicylic Acid
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
Studied range: 0.5–2%, from the trials on the row; needs leave-on contact; judge it after about 6 weeks - 3 · Tolerability
- Standard tolerability
- Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
- United States Pharmacopeia / National Formulary — excipient monograph — USP-NF
← Back to the verdict All rough texture products → Disclose a concentration or correct a fact →
as a moisturizer
Judged as a moisturizer, it comes up short on: seals moisture in, supplies barrier lipids.
- Rule
- J3 → Falls short. Otherwise — when no earlier rule in this group matched.
Category job score below 65 over the features that can be measured from the label (5.1.0: unmeasured features no longer enter at a prior; when under half the spec's weight is measurable there is no job verdict). The sentence names the criterion missed, never 'its basics'. - Measured from the label
- draws in water, softens and smooths, seals moisture in, supplies barrier lipids, right weight for the job
- Tolerability
- Standard tolerability
- Fungal-acne triggers
A verdict is Dermington’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Every rule is public and the same for every product; a brand cannot buy a reading. How we decide · what has changed · disclaimer.